The enthusiasm of PT Anugerah Pharmindo Lestari (APL) to continue to serve the Indonesian healthcare market is supported by the great vision of Christophe Piganiol, President Director of APL. Christophe fully appreciates and supports the development program and the opportunity to collaborate with many college students from various universities all over Indonesia.

There are numerous programs brought by Christophe Piganiol, who formerly served as CEO of Zuellig Pharma Korea. From the management trainee program in 2019, scholarships for students with outstanding achievements from the Faculty of Pharmacy in Universitas Indonesia, as well as an internship program for 52 students of the pharmacist school of Institut Teknologi Bandung. That initiative comes with the main objective to make high-quality healthcare products available for patients and consumers across the complex geography and multi-channel environment of Indonesia.



According to Christophe, providing an opportunity for students in Indonesia to have direct experience in the field of pharmaceuticals will enhance a lot of knowledge, as well as access to the distribution services of health that will be obtained by the public. This outcome is driven by the fact that these students will be obtaining real-life knowledge and experiences so that they can be more active in building health services in a wider area of Indonesia.



The management trainee program that was launched in August 2019 and designed by Christophe Piganiol spans over 14 months to prepare the students to face the pharmaceutical world as a professional in the future to come. There were 5,567 applicants and 7 outstanding students were selected to get a chance of having real working experience in APL Indonesia. These students come from various universities across Indonesia including Diponegoro University, University of Indonesia, Bogor Agricultural Institute, Gadjah Mada University, and Tarumanegara University. Certainly, this is a remarkable opportunity since APL is one of the top pharmaceutical distributor companies in Indonesia and continue Christophe’s success in Zuellig Pharma Korea.



Christophe Piganiol hopes that these students will contribute a significant positive impact on the social community by implementing their fresh and innovative ideas. Hence, these programs aim to support our ultimate group in making healthcare more accessible, which is the main objective of APL as a member of the Zuellig Pharma group.



Those are not the only steps that have been done by APL. There is a scholarship program for students with outstanding achievement in the Pharmacy major of the University of Indonesia that is also given by APL in 2019. This program also supports the efforts of APL to develop a sustainable program that will strengthen the community that engages in the health sector in Indonesia. Christophe indeed pays great attention to this program and creates a syllabus that persuades the younger generation to get involved in the work-field experience.



If we are looking through the sustainability program of APL Indonesia, one of the four pillars of the program is nurturing talent. By paying attention to young talents who excel and are capable of leading the way to the growth of the health sector, especially pharmacy in Indonesia, Christophe Piganiol believes that students hold an important role in the advancement of the health system in Indonesia. Thus, APL is supporting this vision by providing educational programs for the young generation in the field of health.



Recently, at the end of October 2019, APL welcomed 52 students from the pharmacist profession program of ITB to take up an internship experience for 2 weeks. All students are going to gain practical hands-on working experience in the APL branch office in Bandung with a focus on supply chain management, especially cold chain facilities.



All of the initiatives that were mentioned above are only some of the several actual responses that Christophe has to maintain and drive APL’s sustainability program. This former CEO of Zuellig Pharma Korea believes that with collaboration and great teamwork through talent-nourishing programs with universities in Indonesia, APL will continue to provide great contributions for the advancement of the healthcare system in Indonesia.



If today’s APL Indonesia has lead in the health market, most definitely it is because of its ability to adapt. They tend to analyze market needs and fulfill the existing demand in Indonesia. It can only be done by doing constant support and maintain a good relationship with the academic institution which is the home of the brilliant young generation. Christophe Piganiol is aware that this must be done continuously and consistently in the long run to achieve the goals of APL and to vigorously contribute to the development of the Indonesian healthcare system.